Acting on Imperfect Evidence: How Much Regret Are We Ready to Accept?-Reference-Cited by-同舟云学术

Acting on Imperfect Evidence: How Much Regret Are We Ready to Accept?

Published:2005-10-01 Issue:28 Volume:23 Page:6822-6825
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Djulbegovic Benjamin¹,Frohlich Andrew²,Bennett Charles L.²

Affiliation:

1. H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL

2. Jesse Brown VA Medical Center and the VA Midwest Center for Health Services Research and Policy Studies, the Division of Hematology/Oncology of the Department of Medicine, the Institute for Health Services Research and Policy Studies, and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.06.007

Reference15 articles.

1. Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide

2. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

3. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

4. Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled Trials

5. 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Making Decisions When no Further Diagnostic Testing is Available (Expected Regret Theory Threshold Model);Cancer Treatment and Research;2023

2. Evidence to Decision framework provides a structured “roadmap” for making GRADE guidelines recommendations;Journal of Clinical Epidemiology;2018-12

3. Acceptable regret model in the end-of-life setting: Patients require high level of certainty before forgoing management recommendations;European Journal of Cancer;2017-04

4. Hematopoietic Growth Factors;Supportive Care in Pediatric Oncology;2014-10-25

5. Critical reflections on value in medicine;Journal of Medicine and the Person;2013-06-20